MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-244.83M
↓ 162% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-93.47M
Historical baseline
PeriodValueYoY Change
2025$-244.83M-71.1%
2024$-143.09M-164.4%
2023$-54.12M+16.8%
2022$-65.06M-21.4%
2021$-53.58M-50561.4%
2020$-105755.00-